Multiparametric MRI for Diagnosing Small Renal Tumors

NACompletedINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

May 27, 2022

Study Completion Date

April 14, 2023

Conditions
Renal Cancer
Interventions
PROCEDURE

Multiparametric MR imaging (mpMRI)

The main objective of the study is to assess the diagnostic accuracy of mpMRI in small renal tumors. The study characteristics will comply with recommended methods (Quadas, Stard). The population to be included will be representative of patients who would benefit from mpMRI if it is demonstrated to be accurate. In this project, the MR protocol will used the conventional MR sequences either on 1.5 or 3T systems and do not require development. Each center may use their own protocol as long as it includes the mandatory sequences.

Trial Locations (18)

13385

APHM - Hôpital de la Conception, Marseille

31062

CHU Toulouse, Toulouse

33076

CHU Bordeaux, Bordeaux

35033

CHU Rennes, Rennes

37044

CHU Tours, Tours

49933

CHU Angers, Angers

54511

CHU Nancy, Nancy

59000

CHRU Lille, Lille

67091

CHU Strasbourg, Strasbourg

69444

CHU Lyon, Lyon

75020

APHP - Hôpital Tenon, Paris

75743

APHP - Hôpital Necker, Paris

76031

CHU Rouen, Rouen

94010

APHP - Henri Mondor, Créteil

94275

APHP - Hôpital Bicêtre, Le Kremlin-Bicêtre

Unknown

CHU de Grenoble, Grenoble

APHP - Hôpital Bichat, Paris

06001

CHU Nice, Nice

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03470285 - Multiparametric MRI for Diagnosing Small Renal Tumors | Biotech Hunter | Biotech Hunter